Company Filing History:
Years Active: 2013
Title: Lars Van Der Veer: Innovator in Pharmaceutical Chemistry
Introduction
Lars Van Der Veer is a notable inventor based in Alsbach-Hähnlein, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical pathways in cancer treatment.
Latest Patents
Lars holds a patent for 5-alkynyl-pyridines, which are compounds of general formula (I). These compounds are recognized for their potential as inhibitors of the activity of PI3Kalpha. The patent outlines their use in pharmaceutical compositions aimed at treating and preventing diseases characterized by excessive or abnormal cell proliferation, including cancer.
Career Highlights
Lars is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on innovative solutions that address complex health challenges. With a patent portfolio that includes 1 patent, Lars has established himself as a key player in the pharmaceutical industry.
Collaborations
Lars collaborates with talented professionals in his field, including colleagues Tobias Wunberg and Oliver Kraemer. These partnerships enhance the research and development efforts at Boehringer Ingelheim.
Conclusion
Lars Van Der Veer exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions, particularly in cancer treatment, highlight the importance of research and collaboration in advancing medical science.